H.B. Fuller reported second-quarter 2026 revenue growth of 5.8% year on year, with organic growth of 2.6% driven by a 3% pricing increase. Adjusted earnings per share rose 19% to $1.41, while EBITDA increased 9% to $181 million and the EBITDA margin expanded 70 basis points to 19.1%. The company also raised its full-year 2026 guidance, now expecting adjusted EBITDA between $650 million and $675 million and adjusted EPS between $4.60 and $4.90. The pending acquisition of Advanced Medical Solutions is expected to accelerate the company's shift toward higher-growth, higher-margin businesses, though it will temporarily increase leverage to approximately 4 times net debt to adjusted EBITDA.
H B Fuller CompanyH.B. Fuller reported strong Q2 earnings with revenue up 5.8%, adjusted EPS up 19%, and raised full-year guidance.
Advanced Medical Solutions Group plcAdvanced Medical Solutions is being acquired by H.B. Fuller, which is expected to accelerate shift to higher-growth businesses.